Dr. Devon
Christie, Dr. Robin
Carhart-Harris, Dr. Frederick
Barrett and Tura Patterson
will discuss "Psychedelic Research: Moving Beyond the Social and
Political Stigma"
VANCOUVER, BC, Feb. 10, 2022 /CNW/ - Numinus Wellness Inc.
("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF) a
mental healthcare company advancing innovative treatments and safe,
evidence-based psychedelic-assisted therapies, is pleased to
announce that it will participate in the American Association for
the Advancement of Science (AAAS) 2022 Annual Meeting, hosted
virtually February 17-20, 2022.
Dr. Devon Christie, Senior Lead
Psychedelic Programs of Numinus, will join Dr. Robin Carhart-Harris (Imperial College London)
and Dr. Frederick Barrett
(Johns Hopkins University) for a
Scientific Session on "Psychedelic Research: Moving Beyond the
Social and Political Stigma", moderated by Tura Patterson (Usona Institute) on Saturday, February 19, 2022, at 3:00 p.m. ET. This session is open to registered
attendees with Deluxe Access.
Dr. Christie, Dr. Barrett and Ms. Patterson will also convene
for Media Availability on Sunday, February
20, 2022, at 9:00 a.m. ET.
This session is open to registered media only, with complementary
registration.
For general information about the event, please visit
meetings.aaas.org or contact meetings@aaas.org; for media
information, please visit
https://meetings.aaas.org/wp-content/uploads/AM22_MA-grids_final.pdf.
For information about Numinus' participation, please contact
media@numinus.com.
About Numinus
Numinus Wellness helps people to heal and be well through the
development and delivery of innovative mental health care and
access to safe, evidence-based psychedelic-assisted therapies. The
Numinus model – including psychedelic production, research, and
clinic care – is at the forefront of a transformation aimed at
healing rather than managing symptoms for depression, anxiety,
trauma, pain and substance use. At Numinus, we are leading the
integration of psychedelic-assisted therapies into mainstream
clinical practice and building the foundation for a healthier
society.
Learn more at numinus.com and follow us
on LinkedIn, Facebook, Twitter,
and Instagram.
Forward-Looking Statements
Statements and other information contained in this press release
about anticipated future events constitute forward-looking
statements. Forward-looking statements are often, but not always,
identified by the use of words such as "seek", "anticipate",
"believe", "plan", "estimate", "expect" and "intend" and statements
that an event "may", "will", "should", "could" or "might" occur or
other similar expressions. Forward-looking statements are subject
to risks and uncertainties and other factors that could cause
actual results to differ materially from those contained in the
forward-looking statements. Forward-looking statements are based on
estimates and opinions of management at the date the statements are
made. The Company does not undertake any obligation to update
forward-looking statements even if circumstances or management's
estimates or opinions should change except as required by
applicable laws. Investors should not place undue reliance on
forward-looking statements.
View original
content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-aaas-2022-annual-meeting-on-february-17-20-2022-301479205.html
SOURCE Numinus Wellness Inc.
